Michiko Asano Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

1/2021	Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.
1/2020	Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial.
1/2019	Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michiko Asano Research Topics

Disease

5	Body Weight (Weight, Body) 01/2023 - 01/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 07/2016
4	Pleural Effusion (Pleural Effusions) 05/2017 - 03/2010
4	Neoplasms (Cancer) 01/2016 - 07/2009
4	Malignant Mesothelioma 10/2015 - 03/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2019
3	Adenocarcinoma 05/2017 - 07/2009
2	Severe Acute Respiratory Syndrome 01/2023 - 01/2022
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2016 - 07/2009
2	Pleurisy (Pleuritis) 06/2013 - 03/2010
1	Weight Loss (Weight Reduction) 01/2023
1	Overweight 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Fistula 05/2017
1	Hemoptysis 05/2017
1	Small Cell Carcinoma 05/2017
1	Pharyngitis (Sore Throat) 05/2017
1	Cough 05/2017
1	Hypoglycemia (Reactive Hypoglycemia) 07/2016
1	Hemangiosarcoma (Angiosarcoma) 01/2016
1	Inflammation (Inflammations) 10/2015
1	Lymphoma (Lymphomas) 01/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2015
1	Collagen Diseases (Collagen Disease) 06/2013
1	Lung Neoplasms (Lung Cancer) 06/2013
1	Nervous System Diseases (Neurological Disorders) 03/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2011
1	Heart Failure 03/2010
1	Tuberculosis (Tuberculoses) 03/2010

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 01/2021 - 07/2016
5	dapagliflozinIBA 01/2021 - 07/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2016
4	AsbestosIBA 10/2015 - 03/2010
2	cotadutideIBA 01/2023 - 01/2021
2	ChAdOx1 nCoV-19IBA 01/2023 - 01/2022
2	SodiumIBA 01/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 12/2011
2	Pemetrexed (MTA)FDA Link 01/2012 - 12/2011
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SymportersIBA 01/2019
1	AfatinibIBA 05/2017
1	ErbB Receptors (EGF Receptor)IBA 05/2017
1	Docetaxel (Taxotere)FDA Link 05/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2017
1	SuspensionsIBA 05/2017
1	Albumin-Bound Paclitaxel FDA Link 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 06/2013
1	PlatinumIBA 01/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	MesothelinIBA 03/2010
1	Proteins (Proteins, Gene)FDA Link 03/2010
1	Coloring Agents (Dyes)IBA 07/2009

Therapy/Procedure

5	Therapeutics 01/2021 - 07/2009
4	Drug Therapy (Chemotherapy) 05/2017 - 03/2011
2	Chemoradiotherapy 05/2017 - 03/2011
2	Radiotherapy 01/2016 - 03/2011
2	Mastectomy (Mammectomy) 01/2016 - 07/2009
1	Intramuscular Injections 01/2022
1	Stents 05/2017
1	Pneumonectomy (Lung Volume Reduction) 01/2015
1	Cranial Irradiation 03/2011